Logo image of JBOG.PA

JACQUES BOGART (JBOG.PA) Stock Fundamental Analysis

EPA:JBOG - Euronext Paris - Matif - FR0012872141 - Common Stock - Currency: EUR

4.2  -0.1 (-2.33%)

Fundamental Rating

2

Taking everything into account, JBOG scores 2 out of 10 in our fundamental rating. JBOG was compared to 12 industry peers in the Personal Care Products industry. JBOG has a bad profitability rating. Also its financial health evaluation is rather negative. JBOG does not seem to be growing, but still is valued expensively.


Dividend Valuation Growth Profitability Health

Quickly go to:

3

1. Profitability

1.1 Basic Checks

JBOG had negative earnings in the past year.
JBOG had a positive operating cash flow in the past year.
The reported net income has been mixed in the past 5 years: JBOG reported negative net income in multiple years.
In the past 5 years JBOG always reported a positive cash flow from operatings.
JBOG.PA Yearly Net Income VS EBIT VS OCF VS FCFJBOG.PA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20M 40M

1.2 Ratios

The Return On Assets of JBOG (-0.11%) is worse than 75.00% of its industry peers.
JBOG has a Return On Equity of -0.54%. This is in the lower half of the industry: JBOG underperforms 75.00% of its industry peers.
With a Return On Invested Capital value of 4.63%, JBOG is not doing good in the industry: 83.33% of the companies in the same industry are doing better.
JBOG had an Average Return On Invested Capital over the past 3 years of 3.93%. This is significantly below the industry average of 11.81%.
The 3 year average ROIC (3.93%) for JBOG is below the current ROIC(4.63%), indicating increased profibility in the last year.
Industry RankSector Rank
ROA -0.11%
ROE -0.54%
ROIC 4.63%
ROA(3y)-0.56%
ROA(5y)-0.18%
ROE(3y)-2.67%
ROE(5y)-0.98%
ROIC(3y)3.93%
ROIC(5y)3.68%
JBOG.PA Yearly ROA, ROE, ROICJBOG.PA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 10 -10 20

1.3 Margins

JBOG has a worse Operating Margin (5.53%) than 91.67% of its industry peers.
In the last couple of years the Operating Margin of JBOG has remained more or less at the same level.
JBOG's Gross Margin of 52.81% is in line compared to the rest of the industry. JBOG outperforms 41.67% of its industry peers.
In the last couple of years the Gross Margin of JBOG has grown nicely.
Industry RankSector Rank
OM 5.53%
PM (TTM) N/A
GM 52.81%
OM growth 3Y13.73%
OM growth 5Y-1.44%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y1.87%
GM growth 5Y1.91%
JBOG.PA Yearly Profit, Operating, Gross MarginsJBOG.PA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20 40

More info and screens

1

2. Health

2.1 Basic Checks

JBOG has a Return on Invested Capital (ROIC), which is below the Cost of Capital (WACC), which means it is destroying value.
JBOG has about the same amout of shares outstanding than it did 1 year ago.
JBOG has less shares outstanding than it did 5 years ago.
The debt/assets ratio for JBOG is higher compared to a year ago.
JBOG.PA Yearly Shares OutstandingJBOG.PA Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 5M 10M 15M
JBOG.PA Yearly Total Debt VS Total AssetsJBOG.PA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 100M 200M 300M 400M

2.2 Solvency

JBOG has an Altman-Z score of 1.39. This is a bad value and indicates that JBOG is not financially healthy and even has some risk of bankruptcy.
JBOG has a Altman-Z score of 1.39. This is in the lower half of the industry: JBOG underperforms 75.00% of its industry peers.
The Debt to FCF ratio of JBOG is 8.03, which is on the high side as it means it would take JBOG, 8.03 years of fcf income to pay off all of its debts.
Looking at the Debt to FCF ratio, with a value of 8.03, JBOG is doing worse than 75.00% of the companies in the same industry.
JBOG has a Debt/Equity ratio of 2.09. This is a high value indicating a heavy dependency on external financing.
The Debt to Equity ratio of JBOG (2.09) is worse than 91.67% of its industry peers.
Industry RankSector Rank
Debt/Equity 2.09
Debt/FCF 8.03
Altman-Z 1.39
ROIC/WACC0.75
WACC6.21%
JBOG.PA Yearly LT Debt VS Equity VS FCFJBOG.PA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 50M 100M 150M

2.3 Liquidity

JBOG has a Current Ratio of 1.25. This is a normal value and indicates that JBOG is financially healthy and should not expect problems in meeting its short term obligations.
JBOG has a Current ratio (1.25) which is comparable to the rest of the industry.
A Quick Ratio of 0.51 indicates that JBOG may have some problems paying its short term obligations.
JBOG has a Quick ratio of 0.51. This is amonst the worse of the industry: JBOG underperforms 91.67% of its industry peers.
Industry RankSector Rank
Current Ratio 1.25
Quick Ratio 0.51
JBOG.PA Yearly Current Assets VS Current LiabilitesJBOG.PA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 50M 100M 150M 200M

More info and screens

0

3. Growth

3.1 Past

The earnings per share for JBOG have decreased strongly by -111.68% in the last year.
JBOG shows a decrease in Revenue. In the last year, the revenue decreased by -1.29%.
JBOG shows a decrease in Revenue. Measured over the last years, the Revenue has been decreasing by -0.99% yearly.
EPS 1Y (TTM)-111.68%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-56.99%
Revenue 1Y (TTM)-1.29%
Revenue growth 3Y5.51%
Revenue growth 5Y-0.99%
Sales Q2Q%-0.16%

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
JBOG.PA Yearly Revenue VS EstimatesJBOG.PA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 100M 200M 300M
JBOG.PA Yearly EPS VS EstimatesJBOG.PA Yearly EPS VS EstimatesYearly EPS VS Estimates 2016 2017 2018 2019 2020 0.1 0.2 0.3 0.4 0.5

More info and screens

2

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for JBOG. In the last year negative earnings were reported.
Industry RankSector Rank
PE N/A
Fwd PE N/A
JBOG.PA Price Earnings VS Forward Price EarningsJBOG.PA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0 0 0 0 0 0 0

4.2 Price Multiples

100.00% of the companies in the same industry are more expensive than JBOG, based on the Enterprise Value to EBITDA ratio.
Based on the Price/Free Cash Flow ratio, JBOG is valued cheaper than 100.00% of the companies in the same industry.
Industry RankSector Rank
P/FCF 2.5
EV/EBITDA 4.86
JBOG.PA Per share dataJBOG.PA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 5 10 15

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

More info and screens

4

5. Dividend

5.1 Amount

JBOG has a Yearly Dividend Yield of 3.62%.
JBOG's Dividend Yield is rather good when compared to the industry average which is at 2.29. JBOG pays more dividend than 100.00% of the companies in the same industry.
Compared to an average S&P500 Dividend Yield of 2.35, JBOG pays a better dividend.
Industry RankSector Rank
Dividend Yield 3.62%

5.2 History

The dividend of JBOG has a limited annual growth rate of 0.04%.
Dividend Growth(5Y)0.04%
Div Incr Years1
Div Non Decr Years2
JBOG.PA Yearly Dividends per shareJBOG.PA Yearly Dividends per shareYearly Dividends per share 2019 2020 2021 2022 2023 2024 2025 0.1 0.2 0.3 0.4

5.3 Sustainability

JBOG has negative earnings and hence a negative payout ratio. The dividend may be in danger.
DP-664.4%
EPS Next 2YN/A
EPS Next 3YN/A
JBOG.PA Yearly Income VS Free CF VS DividendJBOG.PA Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20M 40M

More info and screens

JACQUES BOGART

EPA:JBOG (7/18/2025, 7:00:00 PM)

4.2

-0.1 (-2.33%)

Chartmill FA Rating
GICS SectorConsumer Staples
GICS IndustryGroupHousehold & Personal Products
GICS IndustryPersonal Care Products
Earnings (Last)04-28 2025-04-28
Earnings (Next)09-25 2025-09-25
Inst Owners0.15%
Inst Owner ChangeN/A
Ins Owners0.37%
Ins Owner ChangeN/A
Market Cap65.90M
Analysts85.71
Price TargetN/A
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 3.62%
Yearly Dividend0.2
Dividend Growth(5Y)0.04%
DP-664.4%
Div Incr Years1
Div Non Decr Years2
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 0.23
P/FCF 2.5
P/OCF 2.02
P/B 0.81
P/tB 1.71
EV/EBITDA 4.86
EPS(TTM)-0.03
EYN/A
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)1.68
FCFY40.05%
OCF(TTM)2.08
OCFY49.58%
SpS18.46
BVpS5.2
TBVpS2.45
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -0.11%
ROE -0.54%
ROCE 6.59%
ROIC 4.63%
ROICexc 5.58%
ROICexgc 7.01%
OM 5.53%
PM (TTM) N/A
GM 52.81%
FCFM 9.11%
ROA(3y)-0.56%
ROA(5y)-0.18%
ROE(3y)-2.67%
ROE(5y)-0.98%
ROIC(3y)3.93%
ROIC(5y)3.68%
ROICexc(3y)4.95%
ROICexc(5y)5.05%
ROICexgc(3y)6.26%
ROICexgc(5y)6.5%
ROCE(3y)5.59%
ROCE(5y)5.24%
ROICexcg growth 3Y12.53%
ROICexcg growth 5Y-0.27%
ROICexc growth 3Y13.27%
ROICexc growth 5Y-1.06%
OM growth 3Y13.73%
OM growth 5Y-1.44%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y1.87%
GM growth 5Y1.91%
F-Score4
Asset Turnover0.73
Health
Industry RankSector Rank
Debt/Equity 2.09
Debt/FCF 8.03
Debt/EBITDA 3.69
Cap/Depr 20.85%
Cap/Sales 2.17%
Interest Coverage 250
Cash Conversion 70.76%
Profit Quality N/A
Current Ratio 1.25
Quick Ratio 0.51
Altman-Z 1.39
F-Score4
WACC6.21%
ROIC/WACC0.75
Cap/Depr(3y)18.79%
Cap/Depr(5y)19.78%
Cap/Sales(3y)2.09%
Cap/Sales(5y)2.35%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-111.68%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-56.99%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)-1.29%
Revenue growth 3Y5.51%
Revenue growth 5Y-0.99%
Sales Q2Q%-0.16%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-21.4%
EBIT growth 3Y19.99%
EBIT growth 5Y-2.42%
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y146.75%
FCF growth 3Y-5.9%
FCF growth 5Y0.49%
OCF growth 1Y102.88%
OCF growth 3Y-7.79%
OCF growth 5Y0.93%